Heart Disease News and Research

Latest Heart Disease News and Research

Quethera receives seed investment funding to develop gene therapy for glaucoma

Quethera receives seed investment funding to develop gene therapy for glaucoma

Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes

Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes

New research supports health strategies to reduce harmful alcohol use in low-income countries

New research supports health strategies to reduce harmful alcohol use in low-income countries

Researchers discover new import pathway used by proteins to reach mitochondria

Researchers discover new import pathway used by proteins to reach mitochondria

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

UK’s GPs, optometrists confirm link between smoking and loss of vision

UK’s GPs, optometrists confirm link between smoking and loss of vision

Active surveillance ‘viable option’ for SRM management

Active surveillance ‘viable option’ for SRM management

Technology enabling fewer invasive cardiac procedures benefits Glasgow children

Technology enabling fewer invasive cardiac procedures benefits Glasgow children

Hip fracture patients have worse outcomes compared to hip replacement patients

Hip fracture patients have worse outcomes compared to hip replacement patients

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

HemoPalm technology can benefit physicians and first responders

HemoPalm technology can benefit physicians and first responders

Novel radiopharmaceutical probe has potential to save lives of patients with ischemic stroke

Novel radiopharmaceutical probe has potential to save lives of patients with ischemic stroke

NUS researchers develop new technique to observe nano-bio interactions

NUS researchers develop new technique to observe nano-bio interactions

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

USF study shows spleen may be a new target for treating stroke-induced chronic inflammation

USF study shows spleen may be a new target for treating stroke-induced chronic inflammation

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

PHE-led study shows England has huge opportunity for lowest disease burden, preventive public health

PHE-led study shows England has huge opportunity for lowest disease burden, preventive public health

2015 Voices for Healthy Kids Progress Report highlights achievements of past year

2015 Voices for Healthy Kids Progress Report highlights achievements of past year

Common hypertension drugs worsen cardiovascular outcomes in hypertensive African Americans

Common hypertension drugs worsen cardiovascular outcomes in hypertensive African Americans

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.